An open label, single arm, extension trial to examine long-term safety of Iclepertin once daily in patients with schizophrenia who have completed previous Iclepertin Phase III trials. (CONNEX-X)

Project: Research

Project Details

StatusActive
Effective start/end date6/12/23 → 5/12/25

Keywords

  • Clinical trial
  • CONNEX-X